These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 69351)
21. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA; Brenner PF; Kletzky OA; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817 [TBL] [Abstract][Full Text] [Related]
22. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins. McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369 [TBL] [Abstract][Full Text] [Related]
23. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Berga SL; Yen SS Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984 [TBL] [Abstract][Full Text] [Related]
24. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study. Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145 [TBL] [Abstract][Full Text] [Related]
25. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels. Frick J; Bartsch G; Weiske WH Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192 [TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay for medroxyprogesterone acetate (Provera) using the 11alpha-hydroxy succinyl conjugate. Royer ME; Ko H; Campbell JA; Murray HC; Evans JS; Kaiser DG Steroids; 1974 May; 23(5):713-30. PubMed ID: 4365969 [TBL] [Abstract][Full Text] [Related]
27. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma. Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814 [TBL] [Abstract][Full Text] [Related]
28. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation. Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592 [TBL] [Abstract][Full Text] [Related]
30. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Moutos D; Smith S; Zacur H Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446 [TBL] [Abstract][Full Text] [Related]
31. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418 [TBL] [Abstract][Full Text] [Related]
32. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty. Warren MP; Mathews JH; Morishima A; Vande Wiele R Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493 [TBL] [Abstract][Full Text] [Related]
33. On the mechanism of action of progestins. Pérez-Palacios G; Fernández-Aparicio MA; Medina M; Zacarías-Villareal J; Ulloa-Aguirre A Acta Endocrinol (Copenh); 1981 Jul; 97(3):320-8. PubMed ID: 6455041 [No Abstract] [Full Text] [Related]
34. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
35. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174 [TBL] [Abstract][Full Text] [Related]
36. Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate. Frick J; Danner C; Kunit G; Joos H; Köhle R Int J Androl; 1982 Jun; 5(3):246-52. PubMed ID: 7118265 [TBL] [Abstract][Full Text] [Related]
37. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073 [TBL] [Abstract][Full Text] [Related]
38. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma. Laatikainen T; Nieminen U; Adlercreutz H Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965 [TBL] [Abstract][Full Text] [Related]
39. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Jeppsson S; Gershagen S; Johansson ED; Rannevik G Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995 [TBL] [Abstract][Full Text] [Related]
40. Direct effects of medroxyprogesterone acetate (MPA) and megestrol acetate (MGA) on rat testicular steroidogenesis. Barbieri RL; Ryan KJ Acta Endocrinol (Copenh); 1980 Jul; 94(3):419-25. PubMed ID: 6968496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]